Return to site

Karikó and Weissman win Nobel Prize in medicine for work that enabled mRNA vaccines against COVID-19

Editor: Zhancheng Liu

October 6, 2023

The Nobel Prize in Medicine for 2023 has been awarded to Hungarian-American scientist Katalin Karikó and American scientist Drew Weissman for their groundbreaking discoveries that paved the way for mRNA vaccines, including those against COVID-19. The Nobel committee in Stockholm recognized their contributions to vaccine development, acknowledging that their work had an unparalleled impact on public health during the pandemic.

Traditionally, vaccine production involved growing and purifying viruses or virus components. However, Karikó and Weissman's pioneering research focused on messenger RNA (mRNA) technology, which revolutionized the vaccine development process. Instead of using whole viruses, mRNA vaccines instruct cells to produce viral proteins, effectively turning the body into a miniature vaccine factory.

Early experiments with mRNA faced significant challenges as the immune system often targeted and destroyed the introduced mRNA. Many researchers lost faith in this approach. However, Karikó, a professor at Szeged University in Hungary and an adjunct professor at the University of Pennsylvania, and Weissman, of the University of Pennsylvania, discovered a tiny modification to RNA building blocks that made it less detectable by the immune system.

Their work laid the foundation for mRNA vaccines, which were crucial in the fight against COVID-19. These vaccines, developed by companies like BioNTech-Pfizer and Moderna, played a pivotal role in saving millions of lives and significantly mitgating the pandemic's impact.

The Nobel committee noted that their discoveries fundamentally changed our understanding of how mRNA interacts with the immune system, leading to the development of highly effective vaccines.

Beyond COVID-19, the potential of mRNA technology extends to a wide range of diseases, including cancer, auto-immune diseases like lupus, and other infectious diseases such as Ebola, malaria, and dengue. It offers a versatile platform for developing new vaccines and therapies.

Karikó and Weissman, who have collaborated for decades, were initially surprised by the Nobel announcement and thought it might be a prank. Their work exemplifies the importance of fundamental research in addressing critical societal needs.

The Nobel Prize carries a cash award of 11 million Swedish kronor ($1 million) and will be presented at ceremonies on December 10, the anniversary of Alfred Nobel's death. The impact of Karikó and Weissman's work has forever changed the landscape of vaccine development, offering hope for addressing not only infectious diseases but also a wide range of medical challenges.